Literature DB >> 29858611

[Proton therapy not superior to IMRT in locally advanced NSCLC].

Almut Dutz1,2, Esther G C Troost1,2,3,4,5,6, Steffen Löck7,8,9,10.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29858611     DOI: 10.1007/s00066-018-1321-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  20 in total

1.  Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.

Authors:  Erik Roelofs; Martijn Engelsman; Coen Rasch; Lucas Persoon; Sima Qamhiyeh; Dirk de Ruysscher; Frank Verhaegen; Madelon Pijls-Johannesma; Philippe Lambin
Journal:  J Thorac Oncol       Date:  2012-01       Impact factor: 15.609

2.  Proton beam therapy - do we need the randomised trials and can we do them?

Authors:  Bengt Glimelius; Anders Montelius
Journal:  Radiother Oncol       Date:  2007-05-11       Impact factor: 6.280

3.  Should randomized clinical trials be required for proton radiotherapy?

Authors:  Michael Goitein; James D Cox
Journal:  J Clin Oncol       Date:  2008-01-10       Impact factor: 44.544

4.  National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer.

Authors:  Kristin A Higgins; Kelli O'Connell; Yuan Liu; Theresa W Gillespie; Mark W McDonald; Rathi N Pillai; Kirtesh R Patel; Pretesh R Patel; Clifford G Robinson; Charles B Simone; Taofeek K Owonikoko; Chandra P Belani; Fadlo R Khuri; Walter J Curran; Suresh S Ramalingam; Madhusmita Behera
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-10-11       Impact factor: 7.038

5.  Individualized dose prescription for hypofractionation in advanced non-small-cell lung cancer radiotherapy: an in silico trial.

Authors:  Aswin L Hoffmann; Esther G C Troost; Henk Huizenga; Johannes H A M Kaanders; Johan Bussink
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-13       Impact factor: 7.038

Review 6.  Consensus Guidelines for Implementing Pencil-Beam Scanning Proton Therapy for Thoracic Malignancies on Behalf of the PTCOG Thoracic and Lymphoma Subcommittee.

Authors:  Joe Y Chang; Xiaodong Zhang; Antje Knopf; Heng Li; Shinichiro Mori; Lei Dong; Hsiao-Ming Lu; Wei Liu; Shahed N Badiyan; Stephen Both; Arturs Meijers; Liyong Lin; Stella Flampouri; Zuofeng Li; Kikuo Umegaki; Charles B Simone; Xiaorong R Zhu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-05-19       Impact factor: 7.038

7.  Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.

Authors:  Steven P Register; Xiaodong Zhang; Radhe Mohan; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-07       Impact factor: 7.038

8.  Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study.

Authors:  Xiaodong Zhang; Yupeng Li; Xiaoning Pan; Li Xiaoqiang; Radhe Mohan; Ritsuko Komaki; James D Cox; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-05       Impact factor: 7.038

9.  Photons, protons or carbon ions for stage I non-small cell lung cancer - Results of the multicentric ROCOCO in silico study.

Authors:  Krista C J Wink; Erik Roelofs; Charles B Simone; David Dechambre; Alina Santiago; Judith van der Stoep; Wim Dries; Julia Smits; Stephen Avery; Filippo Ammazzalorso; Nicolas Jansen; Urszula Jelen; Timothy Solberg; Dirk de Ruysscher; Esther G C Troost
Journal:  Radiother Oncol       Date:  2018-03-12       Impact factor: 6.280

10.  Feasibility of proton pencil beam scanning treatment of free-breathing lung cancer patients.

Authors:  Annika Jakobi; Rosalind Perrin; Antje Knopf; Christian Richter
Journal:  Acta Oncol       Date:  2017-08-01       Impact factor: 4.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.